Skip to main content
HR 7032 117th Congress House Health Administrative law and regulatory procedures Department of Health and Human Services Drug safety, medical device, and laboratory regulation Prescription drugs

Increasing Transparency in Generic Drug Applications Act of 2022

Introduced: March 9, 2022 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 10, 2022
Referred to the Subcommittee on Health.
Mar 9, 2022
Referred to the House Committee on Energy and Commerce.
Mar 9, 2022
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Increasing Transparency in Generic Drug Applications Act of 2022

This bill requires the Food and Drug Administration to inform generic drug applicants, upon request or during review, whether the drug is qualitatively and quantitatively the same as the listed brand-name drug (and if not, the reasons why).

What's happening now March 10, 2022

Referred to the Subcommittee on Health.

 Related & companion bills 2
  • HR 7667 Related bill Food and Drug Amendments of 2022
  • S 4338 Related bill Increasing Transparency in Generic Drug Applications Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 1
All 1 Democratic 1
D
Schrier, Kim
Washington · Apr 1, 2022
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 7032: Increasing Transparency in Generic Drug Applications Act of 2022. 117th Congress. Open America. https://openamerica.io/bill/117-HR-7032/
MLA
"H.R. 7032: Increasing Transparency in Generic Drug Applications Act of 2022." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-7032/.
Bluebook (legal)
H.R. 7032, 117th Cong. (2026), https://openamerica.io/bill/117-HR-7032/.
Markdown link
[H.R. 7032: Increasing Transparency in Generic Drug Applications Act of 2022](https://openamerica.io/bill/117-HR-7032/)
Report a problem